%0 Journal Article %A Marisa Schaeffner %A Paulina Mrozek-Gorska %A Alexander Buschle %A Anne Woellmer %A Takanobu Tagawa %A Filippo M. Cernilogar %A Gunnar Schotta %A Nils Krietenstein %A Corinna Lieleg %A Philipp Korber %A Wolfgang Hammerschmidt %T BZLF1 interacts with chromatin remodelers promoting escape from latent infections with EBV %D 2019 %R 10.26508/lsa.201800108 %J Life Science Alliance %P e201800108 %V 2 %N 2 %X A hallmark of EBV infections is its latent phase, when all viral lytic genes are repressed. Repression results from a high nucleosome occupancy and epigenetic silencing by cellular factors such as the Polycomb repressive complex 2 (PRC2) and DNA methyltransferases that, respectively, introduce repressive histone marks and DNA methylation. The viral transcription factor BZLF1 acts as a molecular switch to induce transition from the latent to the lytic or productive phase of EBV’s life cycle. It is unknown how BZLF1 can bind to the epigenetically silenced viral DNA and whether it directly reactivates the viral genome through chromatin remodeling. We addressed these fundamental questions and found that BZLF1 binds to nucleosomal DNA motifs both in vivo and in vitro. BZLF1 co-precipitates with cellular chromatin remodeler ATPases, and the knock-down of one of them, INO80, impaired lytic reactivation and virus synthesis. In Assay for Transposase-Accessible Chromatin-seq experiments, non-accessible chromatin opens up locally when BZLF1 binds to its cognate sequence motifs in viral DNA. We conclude that BZLF1 reactivates the EBV genome by directly binding to silenced chromatin and recruiting cellular chromatin-remodeling enzymes, which implement a permissive state for lytic viral transcription. BZLF1 shares this mode of action with a limited number of cellular pioneer factors, which are instrumental in transcriptional activation, differentiation, and reprogramming in all eukaryotic cells. %U https://www.life-science-alliance.org/content/lsa/2/2/e201800108.full.pdf